Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
IDT AUSTRALIA LIMITED (IDT)ASX AI Signals has generated 9 signals for IDT during the last 90 days, indicating strong trading activity and ongoing AI monitoring
Latest IDT Signals | |
| 05/07/2026 | SELL |
| 04/07/2026 | SELL |
| 11/06/2026 | SELL |
IDT Share Price | |
| Current Price | $0.031 |
| 52 Week High | $0.100 |
| 52 Week Low: | $0.031 |
| Trading at (% of 52 Week High) | 31.00% |
IDT Australia Limited (ASX: IDT) is a biotechnology company specializing in the development, manufacturing, and commercialization of pharmaceutical products and active pharmaceutical ingredients. The company serves the healthcare sector with a focus on innovative therapies and drug delivery technologies. IDT operates manufacturing facilities in Australia and the United States.
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
The SELL recommendation for IDT Australia Limited is supported by weak price momentum and limited market interest at the current low price level of 0.0310. However, the confidence is moderated by potential volatility in small-cap stocks and limited publicly available financial data.
Clever Leaves Exported Directly to Australia from its GACP-Certified Facility in Portugal
NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade Clever Leaves Exported Directly to Australia from its GACP-Certified Facility in Portugal
NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-gradeLatest IDT AUSTRALIA LIMITED(IDT) News
Clever Leaves Sends First Commercial Flower Shipment to Australia Through Commercial Partnership with IDT Australia Limited
Clever Leaves Sends First Commercial Flower Shipment to Australia Through Commercial Partnership with IDT Australia Limited
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial